PulseSight Therapeutics
Developer of therapeutic proteins designed to treat severe retinal diseases. The company's proteins treat both short and long-term conditions like chronic non-infectious uveitis, degenerative diseases...
Valuation
$0
Share Price
N/A
Total Raised
$57M
Last Round
N/A